• Blog
  • Zika Virus Testing Market Report

    Zika Virus Testing Market Report

    Zika Virus Testing Market Report
    Report code - SRHL289 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Zika Virus Testing Market, Dynamics, and Market Analysis
    See more...

    Impact of COVID-19 on Zika Virus Testing Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Zika Virus Testing Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Zika Virus Testing Market is projected to grow from USD 155.6 million in 2020 to USD 240.2 million by 2026 at a CAGR of over 7.5% during the forecast period.

    Figure: Global Zika Virus Testing Market Size, 2020-2026 (USD Million)

    Zika-Virus-Testing-Market-Forecast

    To know more about the report, click here and get a sample report.

    What is Zika Virus Testing?

    Zika Virus is a mosquito borne disease that mainly affects the pregnant women and their fetus. Presently there is no vaccine developed against the virus, the treatment and testing prevails for cure of the affect. The infection of zika virus is endemic in Southeast Asia and Africa. The subsequent viral spread over the Pacific region has resulted in an outbreak in the developing and developed countries across the globe. 

    Key Players

    Key players operating in the global zika virus testing market are-

    • Quest Diagnostics, Inc. (The U.S),
    • Chembio Diagnostic Systems, Inc. (The U.S),
    • Roche (Switzerland),
    • Biocan Diagnostics, Inc. (Canada),
    • Euroimmun (Germany),
    • Altona Diagnostics (Germany),
    • Abbott Laboratories (The U.S),
    • ELITechGroup (France),
    • F. Hoffmann-La Roche Ltd (Switzerland), and
    • Genekam (Germany).

    Market Dynamics

    The growing prevalence of Zika Virus affected disease, rising emergency approval of POCT testing, growing government funding, and surging medical tourism are some of the key factors boosting the demand for zika virus testing.

    • Favorable government initiatives to develop innovative tests capable to detect the zika virus accurately have further led to a rise in R&D activities by market players, thus augmenting the market growth.
    • However, slow implementation of new advanced technologies in emerging countries coupled with the high cost of branded test kits are likely to hamper the market growth.

    Segment Analysis

    Test Type Trends

    By test type, the zika virus testing market has been segmented into Nucleic Acid Amplification Testing (NAAT) and serological testing.

    • Under these, the serological testing segment held a considerable market share in 2020 and is likely to grow at the highest CAGR during the forecast period.
    • This is mainly attributed to their growing preference over than NAAT test as this test can detect acute as well as late stage zika virus infection, thus proliferates the segment growth.

    Regional Trends

    By region, the North American market witnessed the largest market share in 2020 and is projected to grow at a healthy CAGR during the assessment period.

    • This is mainly attributed to better economic conditions, the rising awareness of the advantages of testing kits, first-rate healthcare facilities, broader government initiatives, and strong business investment in R&D activities, which proliferates regional growth.
    • Around 2 in 20 babies of women with confirmed Zika virus infection during pregnancy in the US states and around 1 in 20 in US territories had Zika-associated birth defects, thereby facilitates the surging need for zika virus testing in the region.

    COVID-19 Impact on Global Zika Virus Testing Market

    The ongoing COVID-19 pandemic has substantially affected the zika virus testing industry due to stringent lockdown measures and curbs on the movement of people. The unprecedented outbreak of coronavirus (SARS?CoV?2) has overshadowed another developing viral threat, which is the Zika flavivirus. The main concern currently to the governments across the globe is the escalating need to screen for and test large numbers of patients for possible COVID-19 infection. Thus, there has been a decline in the tests for the zika virus, thus affecting the industry growth.

    Critical Questions Answered in the Report

    • What are the key trends in the global zika virus testing market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global zika virus testing market?
    • What are the key strategies adopted by the major vendors to lead in the global zika virus testing market?
    • What is the market share of the top vendors?

    ?Wish to know more about the study? Click here.

    Target Audience

    The following is a list of the customers that the Zika Virus testing market aims to convert the most:

    • Zika Virus Testing companies
    • Zika Virus Testing vendors
    • Pharmaceutical companies
    • Virology organizations
    • Hospitals

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    •